Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinoma
首次注射免疫检查点抑制剂的时间会影响肝细胞癌的临床结果和免疫反应。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-014070
Li, Howard L; Charmsaz, Soren; Reisman, Benjamin J; Hayek, Franshisca; Brancati, Madelena; Leatherman, James M; Pazzi, Carlotta; Lee, Royce P; Zhao, Xiyu; Christenson, Eric; Arif, Waqar; Hernandez, Jeric; Ellis, Caroline; Gross, Nicole E; Thoburn, Chris; Chandler, G Scott; Mohindra, Rajat; Bansal, Sanjay; Tang, Laura; Guha, Aditi; Dang, Chi V; Zaidi, Neeha; Jaffee, Elizabeth M; Laheru, Daniel; Zabransky, Daniel J; Barretti, Marina; Ho, Won Jin; Yarchoan, Mark; Nakazawa, Mari